Article
Lower HDAC6 mRNA expression and promoter hypomethylation are associated with RA susceptibility.
Journal of the Formosan Medical Association = Taiwan yi zhi - 1 Aug 2022
Fang Tzu-Jung, Lin Chia-Hui, Lin Yuan-Zhao, Chiu Min-HSi, Li Ruei-Nian, Chan Hua-Chen, Yeh Yao-Tsung, Yen Jeng-Hsien
Abstract excerpt
BACKGROUND/PURPOSE: Recent studies showed that Histone deacetylases 6 (HDAC6) inhibitors could improve arthritis in rheumatoid arthritis (RA) rodent models, whereas lower HDAC6 expression was observed in RA patients' synovial fibroblasts, raising the concerns to use HDAC6 inhibitors to treat RA patients. In the present study, we investigated the involvement of HDAC6 mRNA expression and promoter methylation in RA....
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
